These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 34745145)

  • 41. B cell analysis in SARS-CoV-2 versus malaria: Increased frequencies of plasmablasts and atypical memory B cells in COVID-19.
    Wildner NH; Ahmadi P; Schulte S; Brauneck F; Kohsar M; Lütgehetmann M; Beisel C; Addo MM; Haag F; Schulze Zur Wiesch J
    J Leukoc Biol; 2021 Jan; 109(1):77-90. PubMed ID: 33617048
    [TBL] [Abstract][Full Text] [Related]  

  • 42. To study heterogeneity in SARS-CoV-2 IgG response titre in patients recovered from COVID-19.
    Avneet Garg ; Singh R; Iyer H; Kaur M; Surbhi S; Jindal A; Singh S; Bansal AS; Sati HC; Jindal V
    Monaldi Arch Chest Dis; 2021 Sep; 92(2):. PubMed ID: 34585560
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elements of Th1/Th2 response and disease severity in COVID-19 patients: A short report.
    Akinosoglou K; Delastic AL; Dimakopoulou V; Marangos M; Gogos C
    J Med Virol; 2022 Jan; 94(1):404-406. PubMed ID: 34460125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SARS-CoV-2 infection induces hyaluronan production
    Hellman U; Rosendal E; Lehrstrand J; Henriksson J; Björsell T; Wennemo A; Hahn M; Österberg B; Dorofte L; Nilsson E; Forsell MNE; Smed-Sörensen A; Lange A; Karlsson MG; Ahlm C; Blomberg A; Cajander S; Ahlgren U; Lind A; Normark J; Överby AK; Lenman A
    mBio; 2024 Oct; 15(10):e0130324. PubMed ID: 39302125
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synergy Between NK Cells and Monocytes in Potentiating Cardiovascular Disease Risk in Severe COVID-19.
    Gunasena M; Alles M; Wijewantha Y; Mulhern W; Bowman E; Gabriel J; Kettelhut A; Kumar A; Weragalaarachchi K; Kasturiratna D; Horowitz JC; Scrape S; Pannu SR; Liu SL; Vilgelm A; Wijeratne S; Bednash JS; Demberg T; Funderburg NT; Liyanage NPM
    Arterioscler Thromb Vasc Biol; 2024 Oct; 44(10):e243-e261. PubMed ID: 38989579
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19.
    Rodriguez L; Pekkarinen PT; Lakshmikanth T; Tan Z; Consiglio CR; Pou C; Chen Y; Mugabo CH; Nguyen NA; Nowlan K; Strandin T; Levanov L; Mikes J; Wang J; Kantele A; Hepojoki J; Vapalahti O; Heinonen S; Kekäläinen E; Brodin P
    Cell Rep Med; 2020 Aug; 1(5):100078. PubMed ID: 32838342
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients.
    Lichtensteiger C; Koblischke M; Berner F; Jochum AK; Sinnberg T; Balciunaite B; Purde MT; Walter V; Abdou MT; Hofmeister K; Kohler P; Vernazza P; Albrich WC; Kahlert CR; Zoufaly A; Traugott MT; Kern L; Pietsch U; Kleger GR; Filipovic M; Kneilling M; Cozzio A; Pop O; Bomze D; Bergthaler A; Hasan Ali O; Aberle J; Flatz L
    J Autoimmun; 2023 Nov; 140():103118. PubMed ID: 37826919
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19.
    Bernardes JP; Mishra N; Tran F; Bahmer T; Best L; Blase JI; Bordoni D; Franzenburg J; Geisen U; Josephs-Spaulding J; Köhler P; Künstner A; Rosati E; Aschenbrenner AC; Bacher P; Baran N; Boysen T; Brandt B; Bruse N; Dörr J; Dräger A; Elke G; Ellinghaus D; Fischer J; Forster M; Franke A; Franzenburg S; Frey N; Friedrichs A; Fuß J; Glück A; Hamm J; Hinrichsen F; Hoeppner MP; Imm S; Junker R; Kaiser S; Kan YH; Knoll R; Lange C; Laue G; Lier C; Lindner M; Marinos G; Markewitz R; Nattermann J; Noth R; Pickkers P; Rabe KF; Renz A; Röcken C; Rupp J; Schaffarzyk A; Scheffold A; Schulte-Schrepping J; Schunk D; Skowasch D; Ulas T; Wandinger KP; Wittig M; Zimmermann J; Busch H; Hoyer BF; Kaleta C; Heyckendorf J; Kox M; Rybniker J; Schreiber S; Schultze JL; Rosenstiel P; ;
    Immunity; 2020 Dec; 53(6):1296-1314.e9. PubMed ID: 33296687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peripheral Plasma Cells Associated with Mortality Benefit in Severe COVID-19: A Marker of Disease Resolution.
    Boulanger M; Molina E; Wang K; Kickler T; Xu Y; Garibaldi BT
    Am J Med; 2021 Aug; 134(8):1029-1033. PubMed ID: 33811876
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals.
    Lim J; Puan KJ; Wang LW; Teng KWW; Loh CY; Tan KP; Carissimo G; Chan YH; Poh CM; Lee CY; Fong SW; Yeo NK; Chee RS; Amrun SN; Chang ZW; Tay MZ; Torres-Ruesta A; Leo Fernandez N; How W; Andiappan AK; Lee W; Duan K; Tan SY; Yan G; Kalimuddin S; Lye DC; Leo YS; Ong SWX; Young BE; Renia L; Ng LFP; Lee B; Rötzschke O
    Front Immunol; 2021; 12():710217. PubMed ID: 34867943
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multi-Omics Integration Reveals Only Minor Long-Term Molecular and Functional Sequelae in Immune Cells of Individuals Recovered From COVID-19.
    Liu Z; Kilic G; Li W; Bulut O; Gupta MK; Zhang B; Qi C; Peng H; Tsay HC; Soon CF; Mekonnen YA; Ferreira AV; van der Made CI; van Cranenbroek B; Koenen HJPM; Simonetti E; Diavatopoulos D; de Jonge MI; Müller L; Schaal H; Ostermann PN; Cornberg M; Eiz-Vesper B; van de Veerdonk F; van Crevel R; Joosten LAB; Domínguez-Andrés J; Xu CJ; Netea MG; Li Y
    Front Immunol; 2022; 13():838132. PubMed ID: 35464396
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months.
    Peng P; Hu J; Deng HJ; Liu BZ; Fang L; Wang K; Tang N; Huang AL
    Cell Mol Immunol; 2021 Feb; 18(2):490-491. PubMed ID: 33420358
    [No Abstract]   [Full Text] [Related]  

  • 53. Single-Cell Analysis Reveals the Immune Characteristics of Myeloid Cells and Memory T Cells in Recovered COVID-19 Patients With Different Severities.
    Li X; Garg M; Jia T; Liao Q; Yuan L; Li M; Wu Z; Wu W; Bi Y; George N; Papatheodorou I; Brazma A; Luo H; Fang S; Miao Z; Shu Y
    Front Immunol; 2021; 12():781432. PubMed ID: 35046942
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Persistence of High Levels of Serum Complement C5a in Severe COVID-19 Cases After Hospital Discharge.
    Senent Y; Inogés S; López-Díaz de Cerio A; Blanco A; Campo A; Carmona-Torre F; Sunsundegui P; González-Martín A; Ajona D; Okrój M; Prósper F; Pio R; Yuste JR; Tavira B
    Front Immunol; 2021; 12():767376. PubMed ID: 34868021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Can immunological manipulation defeat SARS-CoV-2? Why G-CSF induced neutrophil expansion is worth a clinical trial: G-CSF treatment against COVID-19.
    Katayama H
    Bioessays; 2021 Feb; 43(2):e2000232. PubMed ID: 33166093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studying the clinical, radiological, histological, microbiological, and immunological evolution during the different COVID-19 disease stages using minimal invasive autopsy.
    D'Onofrio V; Keulen L; Vandendriessche A; Dubois J; Cartuyvels R; Vanden Abeele ME; Fraussen J; Vandormael P; Somers V; Achten R; Dendooven A; Driessen A; Augsburg L; Hellings N; Lammens M; Vanrusselt J; Cox J
    Sci Rep; 2022 Jan; 12(1):1360. PubMed ID: 35079048
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single-Cell RNA Sequencing Reveals HIF1A as a Severity-Sensitive Immunological Scar in Circulating Monocytes of Convalescent Comorbidity-Free COVID-19 Patients.
    May L; Chu CF; Zielinski CE
    Cells; 2024 Feb; 13(4):. PubMed ID: 38391913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SARS-CoV-2 sculpts the immune system to induce sustained virus-specific naïve-like and memory B-cell responses.
    de Campos-Mata L; Tejedor Vaquero S; Tachó-Piñot R; Piñero J; Grasset EK; Arrieta Aldea I; Rodrigo Melero N; Carolis C; Horcajada JP; Cerutti A; Villar-García J; Magri G
    Clin Transl Immunology; 2021; 10(9):e1339. PubMed ID: 34504693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune response pattern across the asymptomatic, symptomatic and convalescent periods of COVID-19.
    Chen Y; Zhang N; Zhang J; Guo J; Dong S; Sun H; Gao S; Zhou T; Li M; Liu X; Guo Y; Ye B; Zhao Y; Yu T; Zhan J; Jiang Y; Wong CCL; Gao GF; Liu WJ
    Biochim Biophys Acta Proteins Proteom; 2022 Feb; 1870(2):140736. PubMed ID: 34774760
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of parenteral nutrition in oxygen escalation/de-escalation in SARS-CoV-2 infected patients who are pre-intubation: A multicenter, observational study.
    Subramanian K; Solomon N; Faillace R; Menon V; Raiszadeh F; Brandeis G
    Clin Nutr ESPEN; 2021 Dec; 46():206-209. PubMed ID: 34857197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.